A plant virus expression vector and its application

By designing a new plant virus vector and replacing TRV2's CP gene sequence and Nimble cloning technology with NC cloning frame, the problem of difficulty in efficiently expressing long fragments in existing TRV vectors is solved, and the efficient expression of target genes and Cas9 genes is achieved. Improved gene editing efficiency.

CN116064647BActive Publication Date: 2024-11-26INST OF TROPICAL BIOSCI & BIOTECH CHINESE ACADEMY OF TROPICAL AGRI SCI
View PDF 0 Cites 4 Cited by

Patent Information

Application Number
CN202211328434.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-27
Publication Date
2024-11-26
Estimated Expiration
2042-10-27

AI Technical Summary

Technical Problem

The existing tobacco fragility virus (TRV) vectors are mainly used to express shorter gene fragments, but have not yet efficiently expressed long fragments or full-length genes, including larger Cas9 genes, which are difficult to meet the needs of gene editing.

Method used

A plant virus vector was designed to replace the CP gene sequence of TRV2 through NC cloning frames, and an expression frame structure containing 35S promoter-TRV2 genomic sequence-NC cloning frame-TRV2 genomic sequence-Nos terminator was constructed, and the expression frame structure containing 35S promoter-TRV2 genomic sequence-NC cloning frame-TRV2 genomic sequence-Nos terminator was constructed, and the Nimble cloning technology was used to connect The target gene and the Cas9 gene form vectors that can efficiently express long fragments.

Benefits of technology

The efficient expression of the target gene and Cas9 gene was achieved, the efficiency of gene editing was improved, and the target sequence was quickly and standardizedly linked to one-step cloning reaction, which significantly improved the efficiency of gene editing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116064647B_ABST
    Figure CN116064647B_ABST
Patent Text Reader

Abstract

The present invention provides a structure, sequence, construction method and application of a plant virus vector in plant gene expression. The key point is that the plant virus vector contains a structure of 35S promoter, 560bp sequence at the 5' end of the tobacco rattle virus TRV2 genome, NC cloning frame, 395bp sequence at the 3' end of the tobacco rattle virus TRV2 genome, and Nos terminator. The target gene is quickly cloned into the vector through a one-step ligation reaction of Nimble cloning (NC cloning), and efficient gene expression and gene editing are performed in plants. The vector provided by the present invention can clone plant genes simply, quickly and efficiently, and is convenient for plant gene expression, silencing or editing research.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biotechnology, and in particular relates to a plant virus vector and its application in gene expression, gene silencing and gene editing. Background Art

[0002] Plant viruses can be used as vector tools for gene expression, gene silencing, and gene editing. Tobacco rattle virus (TRV) has been developed as a vector tool for virus-mediated gene silencing (VIGS) research due to its wide host range and mild symptoms, and has been successfully applied to a variety of plants. However, TRV-based vectors are currently mainly used to express shorter gene fragments for gene silencing, or to express shorter gRNA for gene editing (requiring the use of Cas9-transfected plants). There is no TRV vector that can efficiently express long fragments (full-length genes, including larger Cas9 genes). Summary of the invention

[0003] In view of the problems existing in the prior art, the present invention provides a plant virus vector structure, sequence, construction method and application thereof in plant gene expression.

[0004] The first aspect of the present invention provides a plant virus vector, which is obtained by replacing the CP (coat protein) gene sequence of tobacco rattle virus TRV2 of any vector with an NC cloning frame, and any of the vectors is a vector containing the CP (coat protein) gene sequence of tobacco rattle virus TRV2.

[0005] In a preferred embodiment of the present invention, the plant virus vector contains an expression frame structure of 35S promoter-560bp sequence at the 5' end of tobacco rattle virus TRV2 genome-NC cloning frame-395bp sequence at the 3' end of tobacco rattle virus TRV2 genome-Nos terminator.

[0006] In a preferred embodiment of the present invention, the NC cloning frame is the nucleotide sequence shown in SEQUENCE NO.1.

[0007] In a preferred embodiment of the present invention, the expression cassette structure is the nucleotide sequence shown in SEQUENCE NO.2.

[0008] In a preferred embodiment of the present invention, the plant virus vector is obtained by replacing the nucleic acid sequence between the CP gene and the multiple cloning site (including the CP gene and the multiple cloning site) on the pTRV2 vector with the NC cloning frame structure SEQUENCE NO.1, and is named pNC-TRV2-OE.

[0009] In a preferred embodiment of the present invention, the plant virus vector is constructed according to the following steps:

[0010] 1) Design primers for amplifying the NC cloning frame and amplify the NC cloning frame;

[0011] 2) Enzyme digestion and recovery of tobacco rattle virus vector pTRV2;

[0012] 3) Ligate the NC cloning cassette into the pTRV2 vector.

[0013] In a preferred embodiment of the present invention, the primers in step 1) are: upstream primer (SEQ ID NO.3): aatcacttgcgctaatcaacagtggtctctgtccagtcct, downstream primer (SEQ ID NO.4): ttaatgtcttcgggacatgcggtctcagcagaccacaagt; the amplification template is a vector containing an NC cloning frame.

[0014] In a preferred embodiment of the present invention, in step 2), BglII and SmaI are used for enzyme digestion, and the large vector fragment after enzyme digestion is recovered.

[0015] In a preferred embodiment of the present invention, the reaction system in which the NC cloning frame is connected to the pTRV2 vector in step 3) is 80 ng of the enzyme-cut recovery fragment of pTRV2, 40 ng of the NC cloning frame, 5 ul of Pre-Nimble reaction solution (Nixing Bio), and the reaction conditions are 50°C for 1 hour to obtain the plant virus vector pNC-TRV2-OE.

[0016] The second aspect of the present invention provides a method for constructing a plant virus vector based on Nimble cloning, the method comprising replacing the CP (coat protein) gene sequence of tobacco rattle virus TRV2 of any vector with an NC cloning frame, wherein any vector is a vector containing the CP (coat protein) gene sequence of tobacco rattle virus TRV2.

[0017] In a preferred embodiment of the present invention, the method for constructing the plant virus vector is to replace the nucleic acid sequence between the CP gene and the multiple cloning site (including the CP gene and the multiple cloning site) on the pTRV2 vector with the NC cloning frame structure SEQUENCE NO.1.

[0018] In a preferred embodiment of the present invention, the specific steps of the method for constructing a plant virus vector are:

[0019] 1) Design primers for amplifying the NC cloning frame and amplify the gene fragment;

[0020] 2) Enzyme digestion and recovery of tobacco rattle virus vector pTRV2;

[0021] 3) Ligate the NC cloning cassette into the pTRV2 vector.

[0022] In a preferred embodiment of the present invention, the primers in step 1) are: upstream primer (SEQ ID NO.3): aatcacttgcgctaatcaacagtggtctctgtccagtcct, downstream primer (SEQ ID NO.4): ttaatgtcttcgggacatgcggtctcagcagaccacaagt; the amplification template is a vector containing an NC cloning frame.

[0023] In a preferred embodiment of the present invention, in step 2), BglII and SmaI are used for enzyme digestion, and the large vector fragment after enzyme digestion is recovered.

[0024] In a preferred embodiment of the present invention, the reaction system for connecting the NC cloning frame to the pTRV2 vector in step 3) is 80 ng of pTRV2 enzyme digestion recovery fragment, 40 ng of NC cloning frame, 5 ul of Pre-Nimble reaction solution (Nixing Bio), and the reaction conditions are 50°C for 1 hour.

[0025] The third aspect of the present invention provides a method for constructing a plant virus vector containing a target gene, the method comprising cloning the target gene into the aforementioned plant virus vector.

[0026] In a preferred embodiment of the present invention, the specific steps of the method for constructing a plant virus vector containing a target gene are:

[0027] 1) Design target gene primers and add 20 bp NC universal adapter or NC seamless cloning adapter (NC universal adapter flanking sequence) at both ends of the primers;

[0028] 2) Using the primers in step 1, PCR amplify the target gene and recover the target band;

[0029] 3) The recovered product obtained in step 2 is mixed with the aforementioned plant virus expression vector plasmid, NimbleMix reaction solution is added, and cloning is performed by Nimble cloning to obtain a plant virus expression vector containing the target gene.

[0030] The fourth aspect of the present invention provides a plant gene editing vector, which is obtained by cloning the Cas9 gene and gRNA into the aforementioned plant virus vector.

[0031] In a preferred embodiment of the present invention, the plant gene editing vector is obtained by cloning the Cas9 gene and gRNA into the aforementioned plant virus vector pNC-TRV2-OE.

[0032] In a preferred embodiment of the present invention, the plant gene editing vector is constructed by the following steps:

[0033] 1) Design a pair of primers for amplifying the Cas9 gene, and add a 20 bp NC universal adapter or NC seamless cloning adapter (NC universal adapter flanking sequence) to the 5' end of the upstream primer;

[0034] 2) Using the primers in step 1), PCR amplify the Cas9 gene and recover the target band;

[0035] 3) Design a pair of primers for amplifying the target sequence and gRNA, the upstream primer contains the target sequence, and a 20 bp NC universal adapter or NC seamless cloning adapter (NC universal adapter flanking sequence) is added to the 5' end of the downstream primer;

[0036] 4) Using the primers in step 3), PCR amplifies the target sequence and gRNA, and recovers the target band;

[0037] 5) The recovered product is subjected to Nimble Cloning multi-fragment ligation reaction simultaneously with pNC-TRV2-OE to obtain a vector for plant gene editing.

[0038] The fifth aspect of the present invention provides a method for constructing a plant gene editing vector, which comprises cloning the Cas9 gene and gRNA into the aforementioned plant virus vector.

[0039] In a preferred embodiment of the present invention, the method for constructing the plant gene editing vector is to clone the Cas9 gene and gRNA into the aforementioned plant virus vector pNC-TRV2-OE.

[0040] In a preferred embodiment of the present invention, the specific steps of the method for constructing the plant gene editing vector are:

[0041] 1) Design a pair of primers for amplifying the Cas9 gene, and add a 20 bp NC universal adapter or NC seamless cloning adapter (NC universal adapter flanking sequence) to the 5' end of the upstream primer;

[0042] 2) Using the primers in step 1), PCR amplify the Cas9 gene and recover the target band;

[0043] 3) Design a pair of primers for amplifying the target sequence and gRNA, the upstream primer contains the target sequence, and a 20 bp NC universal adapter or NC seamless cloning adapter (NC universal adapter flanking sequence) is added to the 5' end of the downstream primer;

[0044] 4) Using the primers in step 3), PCR amplifies the target sequence and gRNA, and recovers the target band;

[0045] 5) The recovered product is subjected to Nimble Cloning multi-fragment ligation reaction simultaneously with pNC-TRV2-OE to obtain a vector for plant gene editing.

[0046] The sixth aspect of the present invention provides a method for plant gene editing, the specific steps of which are:

[0047] 1) Clone the Cas9 gene, gRNA and target sequence into the aforementioned plant virus vector to obtain a plant gene editing vector;

[0048] 2) transforming the plant gene editing vector obtained in step 1) into Agrobacterium;

[0049] 3) Injecting or infecting the target plant with the Agrobacterium transformed with the plant gene editing vector in step 2).

[0050] In a preferred embodiment of the present invention, the specific steps of the plant gene editing method are:

[0051] 1) Design a pair of primers for amplifying the Cas9 gene, and add a 20 bp NC universal adapter or NC seamless cloning adapter (NC universal adapter flanking sequence) to the 5' end of the upstream primer;

[0052] 2) Using the primers in step 1), PCR amplify the Cas9 gene and recover the target band;

[0053] 3) Design a pair of primers to amplify the target sequence and gRNA. The upstream primer contains the target sequence, and a 20 bp NC universal adapter or NC seamless cloning adapter (NC universal adapter flanking sequence) is added to the 5' end of the downstream primer.

[0054] 4) Using the primers in step 3), PCR amplifies the target sequence and gRNA, and recovers the target band;

[0055] 5) The recovered product was subjected to Nimble Cloning multi-fragment ligation reaction simultaneously with pNC-TRV2-OE to obtain a vector for plant gene editing;

[0056] 6) transforming the plant gene editing vector obtained in step 5) into Agrobacterium;

[0057] 7) Injecting or infecting the target plant with the Agrobacterium transformed with the plant gene editing vector in step 6).

[0058] A seventh aspect of the present invention provides a kit, which comprises the plant virus vector pNC-TRV2-OE of the present invention and a Nimble Mix reaction solution for Nimble cloning.

[0059] An eighth aspect of the present invention provides a kit, which includes the plant gene editing vector of the present invention and a Nimble Mix reaction solution for Nimble cloning.

[0060] The ninth aspect of the present invention provides the use of the plant virus vector or plant gene editing vector in gene expression, gene silencing or gene editing.

[0061] Compared with the prior art, the technical solution provided by the present invention has the following advantages:

[0062] First, the plant virus vector replaces the CP (capsid protein) gene sequence of tobacco rattle virus TRV2 with the NC cloning frame. Therefore, after the target gene is connected to the vector through NC cloning (or other similar cloning methods), it can be expressed using the CP promoter, thereby enhancing the expression of the target gene. The gene editing efficiency can also be improved based on this vector.

[0063] First, the plant virus vector can express longer gene fragments.

[0064] Second, the plant virus vector is based on Nimble cloning, which can connect the target gene target sequence through a one-step cloning reaction, and has the advantages of being fast, efficient and standardized. BRIEF DESCRIPTION OF THE DRAWINGS

[0065] The following is a detailed description of the vector and kit preparation method of the present invention, as well as the application and beneficial effects in plant gene editing in conjunction with the accompanying drawings and specific embodiments.

[0066] Figure 1 This is a map of the plant virus vector pNC-TRV2-OE. NC Frame: NC cloning frame.

[0067] Figure 2 This is the electrophoresis diagram of the GFP expression vector construction. A: PCR amplification of GFP. M: DL2000 Marker; 1: GFP. B: PCR identification of monoclonal bacterial liquid. M: DL2000 Marker; 1-5: 5 single colonies.

[0068] Figure 3 It is the expression of GFP in tobacco. A: Comparison of pNC-TRV2-OE-GFP and TRV2-GFP, the left side is the injection of TRV2-GFP, and the right side is the injection of pNC-TRV2-OE-GFP. B: Comparison of pNC-TRV2-OE-GFP and empty vector pNC-TRV2-OE (without GFP), the left side is the injection of pNC-TRV2-OE, and the right side is the injection of pNC-TRV2-OE-GFP.

[0069] Figure 4 Tobacco plants were sprayed with pNC-TRV2-OE-GFP to express GFP over a large area.

[0070] Figure 5 It is the amplification of Cas9 and gRNA. 1: Cas9; 2: gRNA; M1: DL15000 Marker; M2: DL2000 Marker. DETAILED DESCRIPTION

[0071] The embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, in which the same or similar reference numerals throughout represent the same or similar elements or elements with the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention. For example, there are many methods for constructing a vector containing the expression cassette structure of the present invention: 35S promoter-560bp sequence at the 5' end of the tobacco crisp virus TRV2 genome-NC cloning frame-395bp sequence at the 3' end of the tobacco crisp virus TRV2 genome-Nos terminator, which is not limited to the construction method of Example 1. Any plant virus vector containing the expression cassette structure of the present invention and its construction method are within the scope of protection of this application. The method for constructing a gene editing vector containing Cas9-gRNA is also not limited to the method described in Example 3. Any method for cloning the Cas9-gRNA structure into a plant virus vector containing the expression cassette structure of the present invention and the vector obtained by this method are within the scope of protection of this application.

[0072] Unless otherwise defined, all technical and scientific terms used in this application have the same meanings as those of ordinary skill in the art to which this application belongs. If specific conditions are not specified in the examples, they are carried out according to the conditions recommended by normal conditions or manufacturers. If the manufacturer is not specified in the reagents or instruments used, they are all conventional products that can be obtained commercially. Although any methods and materials similar or equivalent to the methods and materials described in this application can be used in the practice or testing of this application, preferred methods and materials are still described. In order to make the relevant personnel have a clearer understanding of the terms of this application, the individual terms of this application are defined below.

[0073] Relevant personnel have a relatively clear understanding of the terms of this application, and individual terms of this application are defined below.

[0074] The NC cloning frame refers to a DNA sequence of any origin that is identical to the sequence of the NC cloning frame defined in plasmid pNC-UC (GenBank: MK720605).

[0075] NC universal linker refers to: universal linker 1: cagtggtctctgtccagtcct, universal linker 2: cggtctcagcagaccacaagt, NC seamless cloning linker refers to the flanking sequences of the NC universal linker.

[0076] Example 1 Construction of plant virus (TRV) vector based on Nimble cloning

[0077] (1) Design primers to amplify the NC cloning frame and amplify the gene fragment

[0078] A pair of primers were designed according to the sequence of the NC cloning frame and the vector cloning site, the upstream primer (SEQ ID NO.3): aatcacttgcgctaatcaac agtggtctctgtccagtcct (wherein the underlined sequence is the linker sequence for connection to the expression vector), downstream primer (SEQ ID NO.4): ttaatgtcttcgggacatgc ggtctcagcagaccacaagt (the underlined sequence is the linker sequence for connection to the expression vector).

[0079] Plasmid pNC-UC (GenBank: MK720605) was used as a template, and the two primers were used to perform PCR amplification using PrimeSTAR high-fidelity polymerase (Takara). The PCR amplification program was: 98°C for 30 seconds; 98°C for 10 seconds, 55°C for 20 seconds, 72°C for 20 seconds, 28 cycles; and finally 72°C for 1 minute. The PCR product was detected by agarose gel electrophoresis, and the target band was recovered by gel excision.

[0080] (2) Enzyme digestion and recovery of tobacco rattle virus vector pTRV2

[0081] The pTRV2 plasmid was digested with BglII and SmaI. The digestion system was: pTRV2 1ug, BglII and SmaI 1ul each, digested at 37℃ for 1h. The digestion product was subjected to agarose gel electrophoresis to recover the large vector fragment. This digestion reaction removed the CP gene sequence and multiple cloning site of pTRV2, as well as the sequence between the CP gene and the multiple cloning site.

[0082] (3) Connect the NC cloning frame to the pTRV2 vector

[0083] The recovered restriction digested vector and NC cloning frame were connected. The reaction system was 80ng of vector, 40ng of NC cloning frame, 5ul of Pre-Nimble reaction solution (Nixing Biotechnology), and the reaction conditions were 50℃ for 1h. 5ul of the ligation product was transformed into Escherichia coli competent cells (strain DB3.1). After overnight culture, the single clone obtained was identified by PCR and sequencing to obtain a plant virus vector containing the NC cloning frame with the correct sequence, named pNC-TRV2-OE. The vector map is shown in Figure 1 The sequence of the viral expression frame (including the NC cloning frame) of the vector is shown in SEQUENCE NO.2.

[0084] Example 2 Expression of GFP in tobacco using pNC-TRV2-OE

[0085] (1) GFP gene cloned into vector

[0086] A pair of primers for cloning GFP was designed, the upstream primer (SEQ ID NO.5): aatcacttgcgctaatcaacatggtgagcaagggcgaggagct, the downstream primer (SEQ ID NO.6): ggtctcagcagaccacaagttcacttgtacagctcgtccat. Plasmid pNC-Green-SubC was used as a template, the two primers were used, and PrimeSTAR high-fidelity polymerase (Takara) was used for PCR amplification. The PCR amplification program was: 98°C for 30 seconds; 98°C for 10 seconds, 55°C for 20 seconds, 72°C for 20 seconds, 28 cycles; and finally 72°C for 1 minute. The PCR product was detected by agarose gel electrophoresis. The results are shown in Figure 2 A. The electrophoresis results showed that a band of about 750 bp was amplified, which was consistent with the expected size. The band was recovered by agarose gel electrophoresis. The recovered product was subjected to Nimble Cloning reaction with pNC-TRV2-OE. The reaction system was 80 ng of vector, 40 ng of GFP recovery product, 5 ul of Nimble Mix reaction solution (Nixing Biotechnology), and the reaction conditions were 50°C for 1 hour. 5 ul of the ligation product was transformed into E. coli competent cells. After overnight culture, the monoclonal clone obtained was identified by PCR, and the monoclonal clone with the correct band was obtained ( Figure 2 B) The positive clones were sequenced and identified to obtain a plant virus expression vector containing the GFP gene with the correct sequence, which was named pNC-TRV2-OE-GFP.

[0087] (2) Expression of GFP in tobacco

[0088] Transform the plasmid pNC-TRV2-OE-GFP into Agrobacterium GV3101, pick a single colony of Agrobacterium for PCR identification, and inoculate the single clone containing the target vector into 5ml LB liquid culture medium, shake and culture at 200rpm and 28℃ until OD600 is 1.0-1.5. Centrifuge at 5000rpm for 5 minutes and remove the supernatant. Add 5ml injection buffer (50mM MES pH 5.6, 10mM MgCl2, 100μMacetosyringone) and gently suspend. Centrifuge at 5000rpm for 5 minutes and remove the supernatant. Add injection buffer again until OD600 is 0.1-0.3, place in the dark at room temperature for 1-2 hours, and then use it to inject into the leaves of Nicotiana benthamiana. Use a 1ml syringe without a needle to inject into the lower epidermis of tobacco leaves. Agrobacterium containing TRV2-GFP (containing CP gene, GFP is located downstream of CP gene and fused with CP) and empty vector pNC-TRV2-OE (without GFP) were injected as controls. Three days after injection, GFP expression was observed using ultraviolet light. The results showed that the tobacco leaf area injected with pNC-TRV2-OE-GFP had strong GFP expression, the area injected with TRV2-GFP had weak GFP expression, and the area injected with empty vector pNC-TRV2-OE (negative control) had no fluorescence expression ( Figure 3 ).

[0089] The pNC-TRV2-OE-GFP Agrobacterium injection solution (with 0.1% silwetl-77) was sprayed onto the leaves of the tobacco plant using a spray bottle, and GFP expression was observed using an ultraviolet lamp 7 days later. The results showed that most leaves of the tobacco plant had strong GFP expression ( Figure 4 ).

[0090] Example 3 Using pNC-TRV2-OE to express Cas9 and gRNA to edit tobacco PDS gene

[0091] (1) Cas9 gene and gRNA cloned into vector

[0092] A pair of primers for amplifying the Cas9 gene was designed, the upstream primer (SEQ ID NO.7): aatcacttgcgctaatcaacatggctccgaagaagaagag, the downstream primer (SEQ ID NO.8): gaacccgggtctgtaccgt ggcagggtactattctaccactagaccactggtgctttgtt tcacttcttcttcttcgcct; According to the PDS gene sequence of Nicotiana benthamiana, a target sequence TTGGTAGTAGCGACTCCATG for gene editing was selected to design a pair of primers for amplifying the target sequence and gRNA, the upstream primer (SEQ ID NO.9): acggtacagacccgggttcgattcccggctggtgcaTTGGTAGTAGCGACTCCATG gttttagagctagaaatagc, downstream primer (SEQ ID NO.10): ggtctcagcagaccacaagtggaagaagaaatcgatctgg. SEQ ID NO.8 and SEQ ID NO.9 have 19bp homologous sequences at the 5' end for multi-fragment connection. . Plasmid pNC-HSE401 was used as a template, the above two primers were used, and PrimeSTAR Max high-fidelity polymerase (Takara) was used for PCR amplification. The PCR amplification program was: 98℃ for 30 seconds; 98℃ for 10 seconds, 55℃ for 20 seconds, 72℃ for 50 seconds, 28 cycles; and finally 72℃ for 1 minute. The PCR product was detected by agarose gel electrophoresis. The results are shown in Figure 5 . The electrophoresis results showed that a band of about 4200 bp (consistent with the expected Cas9 gene) and a band of about 200 bp (consistent with the expected gRNA size) were amplified. The two bands were recovered by agarose gel electrophoresis. The recovered product was simultaneously subjected to NimbleCloning multi-fragment ligation reaction with pNC-TRV2-OE. The reaction system was 80 ng of vector, 60 ng of Cas9 recovery product, 30 ng of gRNA recovery product, 5 ul of Nimble Mix reaction solution (Nixing Biology), and the reaction conditions were 50°C for 1 hour. The 5 ul ligation product was transformed into Escherichia coli competent cells, and the monoclones obtained after overnight culture were identified by PCR, and the monoclones with correct bands were obtained. The positive clones were sequenced and identified, and a plant virus expression vector containing the Cas9 gene and gRNA (containing the pds target sequence) with the correct sequence was obtained, named pNC-TRV2-Cas9-pds.

[0093] (2) Editing tobacco PDS gene

[0094] Transform Agrobacterium GV3101 with plasmid pNC-TRV2-Cas9-pds, pick a single Agrobacterium colony for PCR identification, and inoculate the single clone containing the target vector into 5ml LB liquid culture medium, shake and culture at 200rpm and 28℃ until OD600 is 1.0-1.5. Centrifuge at 5000rpm for 5 minutes and remove the supernatant. Add 5ml injection buffer (50mM MES pH 5.6, 10mM MgCl2, 100μM acetosyringone) and gently suspend. Centrifuge at 5000rpm for 5 minutes and remove the supernatant. Re-add injection buffer until OD600 is 0.1-0.3, place in the dark at room temperature for 1-2 hours, and then use it to inject into the leaves of Nicotiana benthamiana. Use a 1ml syringe without a needle to inject into the lower epidermis of tobacco leaves. Agrobacterium containing the plant gene editing vector pNC-HSE401-pds (a non-viral vector containing the same pds target sequence as the viral vector pNC-TRV2-Cas9-pds) was injected as a control. Plant Tissue PCR Kit (Quanshijin) was used to quickly extract DNA from the injection area of ​​the leaf for direct PCR reaction. The amplification primers were: upstream primer (SEQ ID NO.11): ggagtgagtacggtgtgcgaggtcttcgttgggaactg; downstream primer (SEQ ID NO.12): gagttggatgctggatggcctttgtcaatcttcgggtc. The PCR product was subjected to HI-TOM high-throughput sequencing, 3 replicates were tested, and the sequencing results were analyzed and compared. Sequence alignment showed that the gene editing efficiency of the target sequence site was 65.8-79.6% for pNC-TRV2-Cas9-pds, while that of the non-viral vector pNC-HSE401-pds was 45.2-57.7% (Table 1).

[0095] Table 1 Comparison of gene editing efficiency of two vectors

[0096]

[0097] Sequence Listing

[0098] SEQ ID NO.1

[0099] agtggtctctgtccagtcctggcctcgtcggccattctcgactaagttggcagcatcacccgacgcactttgcgccgaataaatacctgtgacggaagatcacttcg

[0100] cagaataaataaatcctggtgtccctgttgataccgggaagccctgggccaacttttggcgaaaatgagacgttgatcggcacgtaagaggttccaactttcaccat

[0101] aatgaaataagatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaacttttgctgacgagaacagggactggtgaaatgcagtt

[0102] taaggtttacacctataaaagagagagccgttatcgtctgtttgtggatgtacagagtgatattattgacacgcctgggcgacggatggtgatccccctggccagtg

[0103] cacgtctgctgtcagataaagtctcccgtgaactttacccggtggtgcatatcggggatgaaagctggcgcatgatgaccaccgatatggccagtgtgccggtatcc

[0104] gttatcggggaagaagtggctgatctcagccaccgcgaaaatgacatcaaaaacgccattaacctgatgttctggggaatataaatgtcaggctcccttatacacag

[0105] ggccagtctggccacttgtggtctgctgagacc

[0106] SEQ ID NO.2

[0107] aagcttgcatgcctgcaggtcaacatggtggagcacgacactctcgtctactccaagaatatcaaagatacagtctcagaagaccagagggctattgagacttttca

[0108] acaaagggtaatatcgggaaacctcctcggattccattgcccagctatctgtcacttcatcgaaaggacagtagaaaaggaagatggcttctacaaatgccatcatt

[0109] gcgataaaggaaaggctatcgttcaagatgcctctaccgacagtggtcccaagatggaccccaccacgaggaacatcgtggaaaaagaagacgttccaaccacg

[0110] tcttcaaagcaagtggattgatgtgatggtcaacatggtggagcacgacactctcgtctactccaagaatatcaaagatacagtctcagaagaccagagggctattg

[0111] agacttttcaacaaagggtaatatcgggaaacctctcggattccattgcccagctatctgtcacttcatcgaaaggacagtagaaaaggaagatggcttctacaaa

[0112] tgccatcattgcgataaaggaaaggctatcgttcaagatgcctctaccgacagtggtcccaaagatggaccccaccacgaggaacatcgtggaaaaagaagacgt

[0113] tccaaccacgtcttcaaagcaagtggattgatgtgatatctccactgacgtaagggatgacgcacaatccccactatccttcgcaagacccttctcttatataaggaa

[0114] gttcatttcatttggagaggataaaaacattgcacctatggtgttgccctggctggggtatgtcagtgatcgcagtagaatgtactaattgacaagttggagaatacg

[0115] gtagaacgtccttatccaacacagcctttatccctctccctgacgaggtttttgtcagtgtaatatttcttttgaactatccagcttagtaccgtacgggaaagtg

[0116] actggtgtgcttatctttgaaatgttactttgggtttcggttctttaggttagtaagaaagcacttgtcttctcatacaaaggaaaacctgagacgtatcgcttacg

[0117] aaaaagaaaaagaatgaaaggtggtggttttaatcgctaccgcaaaaacgatggggtcgttttaattaacttctcctacgcaagcgtctaaacggacgttggggttt

[0118] tgctagtttctttagagaaaaaactagctaagtctttaatgttatcattagagatggcataaatataatacttgtgtctgctgataagatcattttaatttggacgatt

[0119] agacttgttgaactacaggttactgaatcacttgcgctaatcaacagtggtctctgtccagtcctggcctcgtcggccattctcgactaagttggcagcatcacccg

[0120] acgcactttgcgccgaataaatacctgtgacggaagatcacttcgcagaataaataaatcctggtgtccctgttgataccgggaagccctgggccaacttttggcga

[0121] aaatgagacgttgatcggcacgtaagaggttccaactttcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagatttttcaggagctaagga

[0122] agctaaacttttgctgacgagaacagggactggtgaaatgcagtttaaggtttacacctataaaagagagagccgttatcgtctgtttgtggatgtacagagtgata

[0123] ttattgacacgcctgggcgacggatggtgatccccctggccagtgcacgtctgctgtcagataaagtctcccgtgaactttacccggtggtgcatatcggggatgaa

[0124] agctggcgcatgatgaccaccgatatggccagtgtgccggtatccgttatcggggaagaagtggctgatctcagccaccgcgaaaatgacatcaaaaacgccattaa

[0125] cctgatgttctggggaatataaatgtcaggctcccttatacacagggccagtctggccacttgtggtctgctgagaccgcatgtcccgaagacattaaactacggtt

[0126] ctttaagtagatccgtgtctgaagttttaggttcaatttaaacctacgagattgacattctcgactgatcttgattgatcggtaagtcttttgtaatttaattttct

[0127] ttttgattttattttaaattgttatctgtttctgtgtatagactgtttgagatcggcgtttggccgactcattgtcttaccataggggaacggactttgtttgtgtt

[0128] gttattttatttgtattttattaaaattctcaacgatctgaaaaagcctcgcggctaagagattgttggggggtgagtaagtacttttaaagtgatgatggttacaa

[0129] aggcaaaaggggtaaaacccctcgcctacgtaagcgttattacgcccgtctgtacttatatcagtacactgacgagtccctaaaggacgaaacgggagaacgctagc

[0130] caccaccaccaccaccacgtgtgaattacaggtgaccagctcgaatttccccgatcgttcaaacatttggcaataaagtttcttaagattgaatcctgttgccggtc

[0131] ttgcgatgattatcatataatttctgttgaattacgttaagcatgtaataattaacatgtaatgcatgacgttatttatgagatgggtttttatgattagagtcccg

[0132] caattatacatttaatacgcgatagaaaacaaaatatagcgcgcaaactaggataaattatcgcgcgcggtgtcatctatgttactagatc

[0133] SEQ ID NO.3

[0134] aatcacttgcgctaatcaac agtggtctctgtccagtcct

[0135] SEQ ID NO.4

[0136] ttaatgtcttcgggacatgc ggtctcagcagaccacaagt

[0137] SEQ ID NO.5

[0138] aatcacttgcgctaatcaac atggtgagcaagggcgaggagct

[0139] SEQ ID NO.6

[0140] ggtctcagcagaccacaagt tcacttgtacagctcgtccat

[0141] SEQ ID NO.7

[0142] aatcacttgcgctaatcaac atggctccgaagaagaagag

[0143] SEQ ID ON.8

[0144] gaacccgggtctgtaccgtggcagggtactattctaccactagaccactggtgctttgtttcacttcttcttcttcgcct

[0145] SEQ ID ON.9

[0146] acggtacagacccgggttcgattcccggctggtgca TTGGTAGTAGCGACTCCATGgttttagagctagaaatagc

[0147] SEQ ID NO.10

[0148] Ggtctcagcagaccacaagtggaagaagaaatcgatctgg

[0149] SEQ ID ON.11

[0150] ggagtgagtacggtgtgcgaggtcttcgttgggaactg

[0151] SEQ ID ON.12

[0152] gagttggatgctggatggcctttgtcaatcttcgggtc

[0153] According to the disclosure and teaching of the above description, those skilled in the art to which the present invention belongs may also make appropriate changes and modifications to the above embodiments. Therefore, the present invention is not limited to the specific embodiments disclosed and described above, and some modifications and changes to the present invention should also fall within the scope of protection of the claims of the present invention. In addition, although some specific terms are used in this specification, these terms are only for the convenience of description and do not constitute any limitation to the present invention.

Claims

1. A plant virus vector, characterized in that The plant virus vector is obtained by replacing the structure between the CP gene and the multiple cloning site on the tobacco rattle virus vector pTRV2 with the NC cloning frame encoded by SEQ ID NO.

1. The replaced vector contains the expression frame shown in SEQ ID NO.

2.

2. A method for constructing a plant virus vector, the method comprising replacing the structure between the CP gene and the multiple cloning site on the tobacco rattle virus vector pTRV2 with the NC cloning frame encoded by SEQ ID NO.1 to form a vector containing the expression frame shown in SEQ ID NO.

2.

3. A method for constructing a plant virus vector containing a target gene, the method comprising cloning the target gene into the plant virus vector according to claim 1.

4. A plant gene editing vector, characterized in that: The plant gene editing vector is obtained by cloning the Cas9 gene and gRNA into the plant virus vector described in claim 1.

5. A method for plant gene editing, comprising the following steps: 1) cloning the Cas9 gene, gRNA and target gene into the plant virus vector of claim 1 to obtain a plant gene editing vector; 2) transforming the plant gene editing vector obtained in step 1) into Agrobacterium; 3) Infecting the target plant with the Agrobacterium transformed with the plant gene editing vector in step 2).

6. A kit, characterized in that: It includes the plant virus vector as described in claim 1 or the plant gene editing vector as described in claim 4, and also includes a Nimble Mix reaction solution for Nimble cloning.

7. Use of the plant viral vector according to claim 1, or the method for constructing a plant viral vector according to claim 2, or the method for constructing a plant viral vector according to claim 3 to express a target gene in a plant.

8. An application of the plant viral vector as claimed in claim 1, or the method for constructing a plant viral vector as claimed in claim 2, or the method for constructing a plant viral vector as claimed in claim 3, or the plant gene editing vector as claimed in claim 4, or the method for plant gene editing as claimed in claim 5 to express Cas protein and gRNA in plants for gene editing.

Citation Information

Cited By

  • Plant gene editing vector based on TRV, kit and gene editing method

    CN120843591A

  • A TRV-based plant gene editing vector, kit, and gene editing method

    CN120843591B

  • AsCas12f segmented expression mediated gene editing method

    CN121022930A

  • An ascas12f split expression mediated gene editing method

    CN121022930B